Etoricoxib-induced toxic epidermal necrolysis: A fatal case report
Author(s) -
Shatavisa Mukherjee,
SukalyanSaha Roy,
Nikhil Era,
Mala Mukherjee
Publication year - 2018
Publication title -
indian journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.286
H-Index - 59
eISSN - 1998-3751
pISSN - 0253-7613
DOI - 10.4103/ijp.ijp_39_17
Subject(s) - etoricoxib , toxic epidermal necrolysis , medicine , dermatology , adverse effect , cyclooxygenase , pharmacology , side effect (computer science) , analgesic , anesthesia , chemistry , computer science , enzyme , biochemistry , programming language
Cyclooxygenase inhibitors were developed in the quest of enhanced analgesic efficacy devoid of gastric side effects. High usage of etoricoxib by prescription as well as self-administered routes has led to increasing reports of side effects and adverse reactions including dermatologic reactions in 0.1%-0.3% of cases. The present report enumerates a case of toxic epidermal necrolysis induced by etoricoxib.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom